• Cimetidine in Advanced BBB and GI Cancer Assays: Applied Pro

  2026-07-17

  Cimetidine’s unique pharmacological profile as a histamine-2 receptor antagonist and partial H2 receptor agonist unlocks new precision in gastrointestinal cancer and blood-brain barrier assay workflows. This article translates high-impact research and APExBIO’s superior reagent quality into actionable protocols, troubleshooting insights, and innovation strategies for translational scientists.

• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit

  2026-07-17

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit addresses the technical challenge of high-resolution peptide and small protein (1–10 kDa) separation, which is not achievable with conventional Tris-glycine SDS-PAGE. It is strictly intended for research workflows and should not be used for clinical or diagnostic applications.

• Lambda Protein Phosphatase: Precision Control in Circadian P

  2026-07-16

  Explore the advanced utility of Lambda Protein Phosphatase (RNase-free) for dissecting phosphorylation-driven regulation in circadian biology. This in-depth guide connects biochemical specificity with the latest insights into BMAL1 phase separation, offering unique strategies for robust assay optimization.

• BX795: Precision PDK1 Inhibitor Transforming Kinase Assays

  2026-07-16

  BX795 is redefining the landscape for PDK1-targeted research, enabling fine-tuned dissection of cancer and innate immune signaling. This advanced inhibitor offers uniquely validated workflows for modulation of PI3K/Akt/mTOR and TBK1-driven pathways, with practical troubleshooting support for robust, reproducible results.

• HBTU Enables High-Fidelity Peptide Synthesis for Bioluminesc

  2026-07-15

  HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) delivers unmatched racemization resistance and rapid activation in peptide bond formation, streamlining the synthesis of complex, enzyme-responsive probes. Its proven reliability in both standard and advanced workflows makes it the reagent of choice for next-generation peptide-based assay and therapeutic design.

• Sequencing Therapies in Waldenström Macroglobulinemia: Genom

  2026-07-15

  This article reviews recent advances in sequencing therapies for Waldenström Macroglobulinemia (WM), emphasizing the pivotal role of genomic profiling—particularly MYD88 and CXCR4 mutations—in guiding clinical decisions. The reference study highlights the evolving integration of CXCR4 antagonists such as Mavorixafor and underscores the importance of individualized, mutation-informed treatment strategies.

• HBsAg Exploits TBK1 to Suppress IFN and Induce Autophagy in

  2026-07-14

  This study uncovers a mechanism by which hepatitis B surface antigen (HBsAg) manipulates TANK-binding kinase 1 (TBK1) to inhibit type I interferon production and promote early autophagy, potentially enabling persistent HBV infection. These findings clarify the crosstalk between innate immune evasion and autophagy, offering new perspectives for antiviral research.

• Camostat Mesilate: Applied Workflows for Protease Inhibition

  2026-07-14

  Camostat Mesilate stands out as a potent trypsin-like protease inhibitor enabling targeted studies of epithelial sodium channel function and TGF-β signaling. This article details stepwise protocols, troubleshooting strategies, and advanced experimental applications to maximize reliability and interpretability in fibrosis and airway research.

• Evaluating Drug Responses in Cancer: In Vitro Innovations an

  2026-07-13

  Schwartz's dissertation advances the precision of in vitro drug response evaluation in cancer by dissecting the distinct yet overlapping effects of anti-cancer agents on cell proliferation and cell death. These nuanced methodologies refine the interpretation of viability metrics, offering researchers stronger tools for preclinical drug assessment.

• Applied Workflows with HyperFusion High-Fidelity DNA Polymer

  2026-07-13

  HyperFusion™ high-fidelity DNA polymerase offers ultra-precise PCR amplification, enabling robust results even with GC-rich or long DNA templates. This article translates recent neurodegeneration research into actionable protocols, troubleshooting insights, and comparative guidance for advanced genomic workflows.

• Nitrocefin: Chromogenic Cephalosporin Substrate for β-Lactam

  2026-07-12

  Nitrocefin enables rapid, visual, and quantitative assessment of β-lactamase activity, streamlining resistance profiling and inhibitor screening in clinical and research settings. Leveraging advances in substrate specificity, Nitrocefin-based workflows now support nuanced detection of emerging multidrug-resistant pathogens—empowering translational research and antimicrobial innovation.

• Acacetin Targets MAPK1/HMOX1 to Suppress Pyroptosis in IVDD

  2026-07-10

  This study uncovers a novel mechanism by which Duhuo Jisheng decoction (DHJS) and its active component acacetin alleviate intervertebral disc degeneration (IVDD) through modulation of the MAPK1/HMOX1 axis. By inhibiting nucleus pulposus cell pyroptosis and enhancing mitophagy, the research delineates a new therapeutic pathway for degenerative disc disease.

• GABPa Identified as Key Regulator of Beige Adipogenesis in N

  2026-07-09

  This study uncovers the epigenetic landscape of neonatal inguinal white adipose tissue (iWAT) and reveals GA-binding protein alpha (GABPa) as a central regulator of beige adipocyte differentiation. Integration of ChIP-seq and transcriptomic analyses highlights how GABPa-driven chromatin activation underlies distinct metabolic programming in early-life adipose tissue, offering new insights for metabolic research.

• Metformin Hydrochloride Attenuates Vocal Fold Fibrosis via A

  2026-07-09

  This study demonstrates that Metformin Hydrochloride reduces vocal fold fibrosis in a rabbit injury model by activating the AMPK signaling pathway, leading to decreased collagen deposition and fibrotic marker expression. The findings provide mechanistic insight into antifibrotic strategies and highlight the translational potential of AMPK modulation in tissue repair.

• KPT-330 Suppresses Osteoclastogenesis to Alleviate Osteoarth

  2026-07-08

  This study demonstrates that KPT-330, a selective CRM1 inhibitor, effectively inhibits osteoclastogenesis and preserves subchondral bone architecture in a mouse model of osteoarthritis. By blocking NF-κB and MAPK signaling pathways, KPT-330 interrupts bone-cartilage crosstalk, highlighting its translational potential for osteolytic disease intervention.

451 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page